NAVICON PWR 2G DIN 01955543
Status: Cancelled Post Market
Holder: STERIVET, DIVISION OF VÉTOQUINOL N.-A. INC.
Molecule: PENTOXIFYLLINE
Health Canada record
| Active ingredient(s) | PENTOXIFYLLINE 2 G |
|---|---|
| Dosage form | Powder |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1993 |
| Current status date | 12-Feb-2001 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PENTOXIFYLLINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02230090 | APO-PENTOXIFYLLINE SR | APOTEX INC | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Marketed |
| 02543087 | JAMP PENTOXIFYLLINE SR | JAMP PHARMA CORPORATION | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Marketed |
| 02181533 | NAVICON | VETOQUINOL N A INC | Powder | PENTOXIFYLLINE 2 G | Cancelled Post Market |
| 02230401 | NU-PENTOXIFYLLINE-SR 400 MG | NU-PHARM INC | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Cancelled Post Market |
| 01968432 | RATIO-PENTOXIFYLLINE | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Cancelled Post Market |
| 02221977 | TRENTAL | SANOFI-AVENTIS CANADA INC | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Cancelled Post Market |
| 01989685 | TRENTAL SRT 400MG | HOECHST ROUSSEL CANADA INC. | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Cancelled Post Market |
| 00586625 | TRENTAL TAB 400MG | HOECHST CANADA INC. | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Cancelled Post Market |
International API supply for PENTOXIFYLLINE
6 valid EDQM Certificates of Suitability from 6 holders. 5 active FDA Drug Master Files.
Request a quote for NAVICON PWR 2G